Tumor immune evasion arises through loss of TNF sensitivity

Science Immunology
Conor J KearneyJane Oliaro

Abstract

Immunotherapy has revolutionized outcomes for cancer patients, but the mechanisms of resistance remain poorly defined. We used a series of whole-genome clustered regularly interspaced short palindromic repeat (CRISPR)-based screens performed in vitro and in vivo to identify mechanisms of tumor immune evasion from cytotoxic lymphocytes [CD8+ T cells and natural killer (NK) cells]. Deletion of key genes within the tumor necrosis factor (TNF) signaling, interferon-γ (IFN-γ) signaling, and antigen presentation pathways provided protection of tumor cells from CD8+ T cell-mediated killing and blunted antitumor immune responses in vivo. Deletion of a number of genes in the TNF pathway also emerged as the key mechanism of immune evasion from primary NK cells. Our screens also identified that the metabolic protein 2-aminoethanethiol dioxygenase (Ado) modulates sensitivity to TNF-mediated killing by cytotoxic lymphocytes and is required for optimal control of tumors in vivo. Remarkably, we found that tumors delete the same genes when exposed to perforin-deficient CD8+ T cells, demonstrating that the dominant immune evasion strategy used by tumor cells is acquired resistance to T cell-derived cytokine-mediated antitumor effects. We demons...Continue Reading

References

Jan 17, 1996·Journal of the National Cancer Institute·N P RestifoS A Rosenberg
Apr 2, 1998·International Review of Cytology·J A Trapani
Oct 25, 2000·The Journal of Gene Medicine·R M ZwackaM G Dunlop
Jun 11, 2002·The Journal of Biological Chemistry·Bolin LiuZhen Fan
Feb 8, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Christian H PoehleinBernard A Fox
Jun 22, 2007·The Journal of Biological Chemistry·John E DominyMartha H Stipanuk
Nov 3, 2007·Cell Death and Differentiation·S P Cullen, S J Martin
Mar 5, 2008·The Journal of Clinical Investigation·Bin ZhangHans Schreiber
Jun 28, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·M Raza Zaidi, Glenn Merlino
Sep 2, 2011·Analytical Chemistry·Berin A BoughtonUte Roessner
Sep 17, 2011·Current Opinion in Immunology·John Silke
Oct 2, 2012·Arteriosclerosis, Thrombosis, and Vascular Biology·Geun-Young KimBradford C Berk
Aug 22, 2013·Methods in Molecular Biology·David P De Souza
May 23, 2015·Nature Reviews. Immunology·Ilia VoskoboinikJoseph A Trapani
Sep 4, 2015·Molecular Cancer Therapeutics·Ravi K AmaravadiAlex A Adjei
Dec 24, 2015·International Journal of Molecular Sciences·Yuichi TsuchiyaHiroyasu Nakano
Jan 19, 2016·Nature Biotechnology·John G DoenchDavid E Root
Feb 26, 2016·Nature Reviews. Cancer·Belinda S ParkerPaul J Hertzog
Jul 20, 2016·The New England Journal of Medicine·Jesse M ZaretskyAntoni Ribas
Sep 4, 2016·Molecular Cell·Paul R ElliottMads Gyrd-Hansen
Oct 27, 2016·Genome Medicine·Jake S O'DonnellMichele W L Teng
Dec 3, 2016·Cancer Discovery·Daniel Sanghoon ShinAntoni Ribas
Dec 30, 2016·Cancer Discovery·Valsamo AnagnostouVictor E Velculescu
Feb 2, 2017·Journal of Biomedical Science·Chiou-Feng LinTsung-Ting Tsai
Mar 24, 2017·Nature Protocols·Julia JoungFeng Zhang
Jun 14, 2017·Cytokine & Growth Factor Reviews·Matteo Bellone, Angela Rita Elia
Jul 1, 2017·Cell Death and Differentiation·Conor J KearneyJane Oliaro
Jul 21, 2017·Nature·Robert T MangusoW Nicholas Haining
Aug 8, 2017·Nature·Shashank J PatelNicholas P Restifo

❮ Previous
Next ❯

Citations

Feb 13, 2019·PloS One·Riccardo MezzadraTon N Schumacher
Jan 23, 2019·The Journal of Immunology : Official Journal of the American Association of Immunologists·Chuanlin DingJun Yan
Feb 15, 2020·Cells·Emma MorrishJohn Silke
May 19, 2020·EMBO Molecular Medicine·Henry G SmithPascal Meier
Apr 11, 2020·Head & Neck·Maxwell Y Lee, Clint T Allen
Sep 5, 2018·Mammalian Genome : Official Journal of the International Mammalian Genome Society·Camille Guillerey
Apr 16, 2020·Cancers·Marit J van ElsasSjoerd H van der Burg
May 12, 2020·Frontiers in Oncology·María Florencia MercoglianoRoxana Schillaci
Dec 12, 2018·Nature Reviews. Clinical Oncology·Jake S O'DonnellMark J Smyth
Dec 15, 2018·Annual Review of Immunology·Ton N SchumacherPia Kvistborg
Mar 17, 2019·International Journal of Molecular Sciences·Mohamed-Reda BenmebarekSebastian Kobold
Aug 17, 2019·Frontiers in Immunology·Anne MontfortBruno Ségui
Jan 11, 2020·Frontiers in Immunology·Xiaoxuan ZhuangEric O Long
Mar 8, 2019·Nature Medicine·Tanya E KeenanEliezer M Van Allen
Aug 19, 2018·Cancer Immunology, Immunotherapy : CII·Yongyu Shi
Feb 28, 2020·Genome Medicine·Jingxin FuX Shirley Liu
Sep 16, 2020·Nature Reviews. Drug Discovery·Simon J HoggRicky W Johnstone
Sep 26, 2020·Cancer Cell International·Seyed Mohammad MiriAmir Ghaemi
Nov 13, 2019·Nature Reviews. Drug Discovery·Alan HuangBarbara Weber
Aug 10, 2020·Nature Communications·Julia BoshuizenDaniel S Peeper
Jun 23, 2020·Nature Cancer·Mirjam E HoekstraTon N M Schumacher
Dec 10, 2019·Rheumatology·Jan Leipe, Xavier Mariette
May 30, 2020·Cancer Discovery·Davis Y TorrejonAntoni Ribas
Jan 18, 2019·Cancer Immunology Research·Jessica MichieJane Oliaro
Jul 30, 2020·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sailing ShiXiaole Shirley Liu
Oct 23, 2019·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Imran G HousePaul A Beavis
Nov 6, 2020·Cell Metabolism·Xiphias Ge ZhuKıvanç Birsoy
May 14, 2020·Blood Reviews·Rajat Bansal, Ran Reshef
Sep 12, 2019·Cell Reports·Andrew J FreemanJane Oliaro
Jan 28, 2021·Cancers·Théo AccogliFrédérique Végran
Sep 18, 2020·Seminars in Cell & Developmental Biology·Lin Liu, Najoua Lalaoui
Dec 22, 2020·Frontiers in Cell and Developmental Biology·Qian HuangMing Liu
Dec 6, 2020·Signal Transduction and Targeted Therapy·Andrew J FreemanJane Oliaro
Nov 28, 2020·Advanced Biosystems·Zexu Li, Teng Fei

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.

Cellular Immunometabolism

Immunometabolism involves not only the way metabolites are digested by the immune system, but the way in which they can alter the pathway of the immune system. These responses occur in day-to-day healthy cell functioning, but can result in diseases, such as autoimmune disorders. Discover the latest research on cellular immunometabolism here.

CRISPR Ribonucleases Deactivation

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on mechanisms that underlie deactivation of CRISPR ribonucleases. Here is the latest research.

Antigenic Modulation

Antigenic modulation occurs when an antibody cross-links antigens on a cell surface, causing the antigens to become internalized. This can lead to therapeutic failure of monoclonal antibodies as the expression of the antigen becomes decreased on target cells. Find the latest research on antigenic modulation here.

CRISPR in Cancer

CRISPR-Cas system enables the editing of genes to create or correct mutations. Given that genome instability and mutation is one of the hallmarks of cancer, the CRISPR-Cas system is being explored to genetically alter and eliminate cancer cells. Here is the latest research.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.